Global WholeHealth Partners Corporation develops and markets various in-vitro diagnostic test kits in the United States. The company offers rapid diagnostic tests, such as the CoVid-19 test, whole blood Ebola test, whole blood Zika test, whole blood rapid TB test, and various other tests for over-the-counter or consumer-use, as well as for point-of-care, which includes hospitals, physicians' offices, and medical clinics. It provides tests for various diseases, such as Ebola, zika, dengue, malaria, influenza, tuberculosis, coronaviruses, and other vector-borne diseases. Global WholeHealth Partners Corporation was incorporated in 2013 and is based in San Clemente, California.
Show more...
CEO
Country
US
ISIN
US37959N1028
Listings
0 Comments
Share your thoughts
FAQ
What is Global Wholehealth Partners stock price today?▼
The current price of GWHP is $0 USD — it has increased by +0% in the past 24 hours. Watch Global Wholehealth Partners stock price performance more closely on the chart.
What is Global Wholehealth Partners stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Global Wholehealth Partners stocks are traded under the ticker GWHP.
What were Global Wholehealth Partners earnings last quarter?▼
GWHP earnings for the last quarter are 0 USD per share, whereas the estimation was 0 USD resulting in a +NaN% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Global Wholehealth Partners revenue for the last year?▼
Global Wholehealth Partners revenue for the last year amounts to 7,375 USD.
What is Global Wholehealth Partners net income for the last year?▼
GWHP net income for the last year is -5.15M USD.
In which sector is Global Wholehealth Partners located?▼
Global Wholehealth Partners operates in the Other sector.
When did Global Wholehealth Partners complete a stock split?▼
Global Wholehealth Partners has not had any recent stock splits.